Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
and PRMT4 (CARM1) (IC50s of 166 µM
Santucci Z
None of the mice have to be removed from the study because of adverse side effects of the treatment
InChiKey: KYJYDNKATOCUIR-UHFFFAOYSA-N
CRT0044876 inhibits both the exonuclease and AP endonuclease activities of exonuclease III
PF-5006739 Size:Contact [email protected] for quotation and PRMT4 (CARM1) (IC50s ofPF 5006739 is a potent and selective inhibitor of CK1 with IC50s of 3. 9 nM and 17. 0 nM, respectively. PF 5006739 is a potential therapeutic agent for a range of psychiatric disorders with low nanomolar in vitro potency for CK1 and high kinome selectivity. PF 5006739 attenuats opioid drug seeking behavior in a rodent operant reinstatement model in animals in a dose dependent manner. PF 5006739 improves glucose tolerance in both diet induced obesity
US$ 10999.50
US$ 3849.50
US$ 699.50
US$ 1084.50
US$ 1399.50
US$ 1399.50
US$ 3159.50
US$ 1589.50
US$ 1624.50
US$ 1300.00
US$ 1599.50
US$ 799.50
US$ 1634.50
US$ 2299.50
US$ 3500.00
US$ 2749.50
US$ 1349.50
US$ 2509.50
US$ 1499.50